Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta
Supriya K
SK
Department of Medicine, Section of Hematology/Oncology, 5841 South Maryland Ave, MC 2115 Chicago, IL 60637, USA. sgupta@medicine.bsd.uchicago.edu
Vogelzang
Nicholas
N
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care
D018931:Antineoplastic Agents, Hormonal